| Transient Efficacy of Octreotide and Pasireotide (SOM230) Treatment in GIP-dependent Cushing's Syndrome. | |
| | |
MedLine Citation:
|
PMID: 21264796 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We studied a 55-year old woman presenting with features of Cushing's syndrome associated with metabolic abnormalities including severe hypertension and type 2 diabetes. Urinary free cortisol excretion was within normal limits, but an unusual diurnal cortisol rhythm was observed with low morning and high postprandial levels, associated with the absence of cortisol suppression after dexamethasone, suggesting the possibility of GIP-dependent Cushing's syndrome. The diagnosis was confirmed by further investigations, showing significant plasma cortisol responses after a mixed meal test and after oral, but not intravenous glucose administration, as well as ACTH-independent bilateral macronodular adrenal hyperplasia (AIMAH). An aberrant increase in cortisol was also observed after glucagon and terlipressin injections. The patient was first treated with octreotide 100-250 μg thrice daily for 6 months, then with the new multi-ligand somatostatin analogue (SOM 230) 450-900 μg twice daily for 3 months. Although inducing a significant acute suppression of post-prandial cortisol response, both drugs had no effects on the clinical and metabolic abnormalities associated with Cushing's syndrome and new tests performed at the end of each treatment period confirmed escape of post-meal cortisol suppression to therapy. The patient finally underwent a bilateral adrenalectomy, which markedly improved her medical condition and allowed in vitro confirmation by real time RT-PCR quantification of a high aberrant expression of GIP receptor mRNA in adrenal tissue. This case report illustrates the lack of sustained efficacy of somatostatin analogues on GIP-dependent Cushing's syndrome, independent of their affinity for the different somatostatin receptor subtypes. |
| | |
Authors:
|
V Preumont; L M Mermejo; P Damoiseaux; A Lacroix; D Maiter |
Related Documents
:
|
1055406 - Patients with ehlers-danlos syndrome type iv lack type iii collagen. 9761296 - Polyunsaturated fatty acids are lower in blood lipids of usher's type i but not usher's... 7546986 - Myocardial infarction resulting from coronary artery dissection in an adolescent with e... 1869336 - Mediastinal haematoma in ehlers-danlos syndrome. 11305056 - Wallstent endovascular prosthesis for the treatment of superior vena cava syndrome. 11717546 - Marginal zone b-cell lymphoma of the salivary gland arising in chronic sclerosing siala... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-24 |
Journal Detail:
|
Title: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme Volume: - ISSN: 1439-4286 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0177722 Medline TA: Horm Metab Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Division of Endocrinology, Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Menin Interacts with ?-Catenin in Osteoblast Differentiation.
Next Document: Increased Gallium-68 DOTATOC Uptake in Normal Thyroid Glands.